Life Sciences Times

KalVista Pharmaceuticals Names Bilal Arif Chief Operating Officer and Linea Aspesi Chief People Officer

Stoke Therapeutics Names Ian F. Smith Chief Executive Officer

Encora Therapeutics Appoints Nadim Yared as Chairman and Chief Executive Officer

Dante Omics AI and Global Partners Publish Most Complete Genome of RPE-1 Cell Line in Nature Communications

Twist Bioscience Highlights Role in Science Publication on Biosecurity Screening for AI-Assisted Protein Design

FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Bruker Secures $10 Million in NIH- and NSF-Funded NMR Orders from NYSBC, University of Delaware and Northwestern University

Kernal Bio Relocates to Lilly Gateway Labs to Advance In Vivo Cell Therapies

Sarepta to Showcase New Neuromuscular Data at World Muscle Society Congress

Hologic Secures FDA Clearance and CE Mark for Panther Fusion Assays Targeting Infectious Gastroenteritis Pathogens